Drug Approval | November 08, 2022
Zydus receives EIR with VAI from USFDA for Moraiya facility
The USFDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI)
The USFDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI)
With the receipt of the EIR, the inspection stands successfully closed.
The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
The inspection was a Pre-Approval cum cGMP inspection and it covered 15 ANDAs
FDA changes inspection classification of the facility to Voluntary Action Indicated
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
